Annette North - Jun 15, 2021 Form 4 Insider Report for Turning Point Therapeutics, Inc. (TPTX)

Role
EVP, General Counsel & Secty.
Signature
/s/ Annette North
Stock symbol
TPTX
Transactions as of
Jun 15, 2021
Transactions value $
-$900,433
Form type
4
Date filed
6/16/2021, 05:16 PM
Previous filing
May 7, 2021
Next filing
Aug 31, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPTX Common Stock Options Exercise $255K +15K +121.31% $17.00* 27.4K Jun 15, 2021 Direct F1
transaction TPTX Common Stock Sale -$430K -5.67K -20.71% $75.94 21.7K Jun 15, 2021 Direct F1, F2
transaction TPTX Common Stock Sale -$209K -2.7K -12.44% $77.37 19K Jun 15, 2021 Direct F1, F3
transaction TPTX Common Stock Sale -$516K -6.63K -34.92% $77.82 12.4K Jun 15, 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPTX Stock Option (right to buy) Options Exercise $0 -15K -8.84% $0.00 155K Jun 15, 2021 Common Stock 15K $17.00 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020.
F2 The weighted average sale price for the transaction reported was $75.94, and the range of prices were between $75.49 and $76.35. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
F3 The weighted average sale price for the transaction reported was $77.37, and the range of prices were between $76.575 and $77.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
F4 The weighted average sale price for the transaction reported was $77.82, and the range of prices were between $77.59 and $78.21. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
F5 One-fourth of the option vested on April 15, 2020. Thereafter, 1/48th of the Option vests on a monthly basis over 36 months until the option becomes fully vested.